Remission of cold hemagglutinin disease induced by rituximab therapy.
Sparling
T G
TG
Andricevic
M
M
Wass
H
H
D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000097:blood / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D003131:Combined Modality Therapy; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D012074:Remission Induction / Q000379:methods; D000069283:Rituximab; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D006454:Hemoglobins; D000069283:Rituximab; D011241:Prednisone